LY
Healthcare & Life Sciences
Lyell
United Stateslyell.com
Lyell is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Lyell
Lyell is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Lyell develops next-generation CAR T-cell therapies aimed at providing one-time treatments that deliver lasting remissions for patients with cancer, including hematologic malignancies and solid tumors.
Explore Lyell's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.